Dm. Isaza et al., IMMUNOBLOT ANALYSIS OF LEISHMANIA-PANAMENSIS ANTIGENS IN SERA OF PATIENTS WITH AMERICAN CUTANEOUS LEISHMANIASIS, Journal of clinical microbiology, 35(12), 1997, pp. 3043-3047
Sera from 86 Colombian patients with parasitologically confirmed cutan
eous leishmaniasis were studied by Immunoblot analysis in order to ide
ntify a specific pattern for Leishmania infection, A soluble extract o
f Leishmania panamensis was used as the antigen, Sera from patients wi
th Chagas' disease and sera from patients with no record of infection
with trypanosomatids were also studied, The sera from patients with cu
taneous leishmaniasis specifically recognized fractions of 120 kDa (76
.7%), 123 and 129 kDa (69.7%), 138 kDa (61.6%), 141 kDa (53.4%), and 7
8 kDa (44.1%), No band common to all patients infected with Leishmania
parasites was found at the time of diagnosis, Likewise, the pattern o
f immunoblot change after the patients were treated and apparently cur
ed with meglumine antimoniate (Glucantime) was studied by evaluating s
era pretreatment and 1 year posttreatment, Only minor changes in the c
olor intensity at the same serum dilution between pre-and posttreatmen
t sera were found, although the antibody titers by indirect immunofluo
rescence were negative for the posttreatment sample, This study shows
that Western blot analysis is a more sensitive test for the detection
of anti-Leishmania antibodies, However, the importance of whether the
presence of antibodies correlates with the presence of Leishmania anti
gens could not be resolved by the data obtained from this study.